Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands		Total	Common Shares	Class B Common Stock	Common Stock	Common Stock Common Shares	Common Stock Class B Common Stock	Capital Surplus	Retained Earnings	Retained Earnings Common Shares	Retained Earnings Class B Common Stock	Accumulated Other Comprehensive Loss
Balance at beginning of period at Aug. 27, 2022		$ 1,915,871				$ 1,508	$ 359	$ 93,131	$ 1,845,163			$ (24,290)
Balance at beginning of period (in shares) at Aug. 27, 2022						15,075	3,590
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		33,957							33,957
Change in fair value of derivatives	[1]	52										52
Foreign currency translation		(1,778)										(1,778)
Dividends declared Common Stock			$ (4,680)	$ (890)						$ (4,680)	$ (890)
Share-based compensation, net	[2]	(567)						(567)
Share-based awards exercised, net	[1]	1				$ 1
Share-based awards exercised, net (in shares)	[1]					20
Balance at end of period at Nov. 26, 2022		1,941,966				$ 1,509	$ 359	92,564	1,873,550			(26,016)
Balance at end of period (in shares) at Nov. 26, 2022						15,095	3,590
Balance at beginning of period at Aug. 27, 2022		1,915,871				$ 1,508	$ 359	93,131	1,845,163			(24,290)
Balance at beginning of period (in shares) at Aug. 27, 2022						15,075	3,590
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		51,767
Foreign currency translation		(3,251)
Balance at end of period at Feb. 25, 2023		1,955,088				$ 1,510	$ 359	94,861	1,885,788			(27,430)
Balance at end of period (in shares) at Feb. 25, 2023						15,103	3,590
Balance at beginning of period at Nov. 26, 2022		1,941,966				$ 1,509	$ 359	92,564	1,873,550			(26,016)
Balance at beginning of period (in shares) at Nov. 26, 2022						15,095	3,590
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		17,810							17,810
Change in fair value of derivatives	[1]	59										59
Foreign currency translation		(1,473)										(1,473)
Dividends declared Common Stock			(4,682)	(890)						(4,682)	(890)
Share-based compensation, net	[2]	2,297						2,297
Share-based awards exercised, net	[1]	1				$ 1
Share-based awards exercised, net (in shares)	[1]					8
Balance at end of period at Feb. 25, 2023		1,955,088				$ 1,510	$ 359	94,861	1,885,788			(27,430)
Balance at end of period (in shares) at Feb. 25, 2023						15,103	3,590
Balance at beginning of period at Aug. 26, 2023		2,003,960				$ 1,510	$ 359	99,303	1,926,549			(23,761)
Balance at beginning of period (in shares) at Aug. 26, 2023						15,104	3,590
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		42,325							42,325
Change in fair value of derivatives	[1]	(12)										(12)
Foreign currency translation		(151)										(151)
Dividends declared Common Stock			(4,993)	(948)						(4,993)	(948)
Repurchase of Common Stock		(255)						(10)	(245)
Repurchase of common stock (in shares)					(2)
Share-based compensation, net	[2]	244						244
Share-based awards exercised, net	[1]	3				$ 3
Share-based awards exercised, net (in shares)	[1]					26
Balance at end of period at Nov. 25, 2023		2,040,173				$ 1,513	$ 359	99,537	1,962,688			(23,924)
Balance at end of period (in shares) at Nov. 25, 2023						15,128	3,590
Balance at beginning of period at Aug. 26, 2023		2,003,960				$ 1,510	$ 359	99,303	1,926,549			(23,761)
Balance at beginning of period (in shares) at Aug. 26, 2023						15,104	3,590
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		62,782
Foreign currency translation		768
Balance at end of period at Feb. 24, 2024		2,049,685				$ 1,509	$ 359	101,197	1,969,659			(23,039)
Balance at end of period (in shares) at Feb. 24, 2024						15,087	3,590
Balance at beginning of period at Nov. 25, 2023		2,040,173				$ 1,513	$ 359	99,537	1,962,688			(23,924)
Balance at beginning of period (in shares) at Nov. 25, 2023						15,128	3,590
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		20,457							20,457
Change in fair value of derivatives	[1]	(34)										(34)
Foreign currency translation		919										919
Dividends declared Common Stock			$ (4,976)	$ (948)						$ (4,976)	$ (948)
Repurchase of Common Stock		(7,864)				$ (4)		(298)	(7,562)
Repurchase of common stock (in shares)						(45)
Share-based compensation, net	[2]	1,958						1,958
Share-based awards exercised, net (in shares)	[1]					4
Balance at end of period at Feb. 24, 2024		$ 2,049,685				$ 1,509	$ 359	$ 101,197	$ 1,969,659			$ (23,039)
Balance at end of period (in shares) at Feb. 24, 2024						15,087	3,590

[1] These amounts are shown net of the effect of income taxes.

[2] These amounts are shown net of any shares withheld by the Company to satisfy certain tax withholding obligations in connection with the vesting of certain restricted stock units.